Investor's Business Daily on MSN18h
AstraZeneca Could Pay $4.5 Million In China Scandal. Here's Why Shares Jumped.
AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.
STAT3h
Pharmalittle: We’re reading about a China probe of AstraZeneca, a ‘troubling’ Super Bowl ad, and more
A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super ...
Pharmaceutical Technology on MSN18h
AstraZeneca’s shares rise as it addresses China investigation
In addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company ...
BUSINESS LIVE BofE cuts base rate; FTSE record high; AstraZeneca flags China fine
The FTSE 100 finished up 103.99 at 8727.28 - a new record closing high. It also hit a new intraday record of 8,767.50 earlier ...
Zacks.com on MSN2h
Pharma Stock Roundup: PFE, LLY, NVO, LLY and AZN's Q4 Earnings Update
This week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, ...
AZN Q4 Earnings Lag, Sales Beat, Stock Up on China Probe Update
AstraZeneca reports mixed results in the fourth quarter. It gains in pre-market after assuring investors that the business impact of the Chinese investigations remains minor.
India's central bank cuts repo rate for first time in nearly 5 years
The Monetary Policy Committee, which consists of three RBI and three external members, cut the repo rate by 25 basis points, ...